Epilepsy Comprehensive Update and Board Review
May 8-9, 2024
Westin Houston Medical Center | 1709 Dryden Rd. | Houston, Texas 77030
The Epilepsy Comprehensive Update & Board Review is an educational symposium whose aim is to educate neurologists, APPs, neurology residents, and epilepsy fellows involved in the treatment of patients with epilepsy.
This year’s course will expand attendees’ knowledge and understanding of epilepsy and will demonstrate how to offer top quality epilepsy care to patients. The event will include a series of lectures designed to prepare attendees for the Epilepsy Boards.
Some of the many exciting highlights include:
- Focused lectures on all aspects of epilepsy care, including pharmacologic therapies, diagnostic testing, and surgical therapies.
- Discussion of etiology and electroclinical syndromes in both adult and pediatric patients.
- A lecture and discussion around SUDEP.
For more information, email tirn.events@uth.tmc.edu.
Learning Objectives
- Identify clinical features that support a diagnosis of epilepsy and specific epilepsy syndromes.
- Recognize normal, abnormal and epileptiform EEG patterns.
- Appropriately choose antiseizure medications for patients with epilepsy based on clinical history, comorbidities and epilepsy subtype.
- Identify appropriate diagnostic testing in persons with epilepsy including testing in drug resistant epilepsy patients.
Accreditation Statement/Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company and UTHealth Houston Neurosciences. Antidote is accredited by the ACCME to provide continuing medical education for physicians.
Antidote designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Educational Program
Day 1 | ||||
7:30 am: Registration and Breakfast | ||||
AM Session | ||||
Basics of EEG and Epilepsy Classification | ||||
8 am: Welcome Remarks | ||||
EEG | ||||
Adult EEG | ||||
8:10 am: Electrophysiologic Basis of EEG and Normal EEG—Fabio Nascimento, MD | ||||
8:30 am: Normal Variants—Fabio Nascimento, MD | ||||
8:50 am: Interictal EEG—Brandy Ma, MD, MPH | ||||
9:10 am: Ictal EEG—Jay Gavvala, MD | ||||
9:30 am: Q&A | ||||
9:40 am: Break | ||||
Pediatric EEG | ||||
9:55 am: Neonatal—Elaine Seto, MD, PhD | ||||
10:15 am: Children—Gretchen von Allmen, MD | ||||
10:35 am: ICU EEG—Sarah Schmitt, MD | ||||
10:55 am: Q&A | ||||
Epilepsy Classification | ||||
11:05 am: Adult—Stephan Schuele, MD, MPH | ||||
11:25 am: Pediatric—Deepa Sirsi, MD | ||||
11:45 am: Semiological Case Studies—Stephan Schuele, MD, MPH | ||||
12:15 pm: Q&A | ||||
12:30 pm: Lunch | ||||
PM Session | ||||
Epilepsy and Nonepileptic events and Care of Persons with Epilepsy | ||||
1:15 pm: The Care of Women with Epilepsy—Jennifer DeWolfe, DO | ||||
1:35 pm: Safety Considerations with Epilepsy—Jennifer DeWolfe, DO | ||||
Etiology and Electroclinical Syndromes | ||||
1:55 pm: Adult Etiology and Electroclinical Syndromes —Brandy Ma, MD | ||||
2:55 pm: Q&A | ||||
3:05 pm: Break | ||||
3:20 pm: Genetics in Clinical Practice: When to order testing and how to interpret results—Dennis Lal, PhD | ||||
3:50 pm: Organic and Psychogenic Nonepileptic Events—Michael Watkins, MD | ||||
4:20 pm: The Neuropsychiatry of Epilepsy—Yosefa Modiano, PhD | ||||
4:40 pm: Closing the Loop – the Pathology of Epilepsy—Meena Bhattacharjee, MD | ||||
5:10 pm: Q&A | ||||
5:20 pm: Adjourn | ||||
5:30 pm: Welcome Reception — All are invited | ||||
Day 2 | ||||
7:30 am: Registration and Breakfast | ||||
AM Session | ||||
Antiseizure Medication Considerations and Epilepsy Comorbidities | ||||
8 am: Status Epilepticus (Semiology and Treatment) Therapy Update—Sarah Schmitt, MD | ||||
8:20 am: Special Considerations in Pediatric Drug Therapy —Gloria Diaz-Medina, MD | ||||
8:50 am: Antiseizure Medication Properties and Role in Therapy, Part 1—Bassel Abou-Khalil, MD | ||||
10 am: Break | ||||
10:15 am: Antiseizure Medication Properties and Role in Therapy, Part 2—Bassel Abou-Khalil, MD | ||||
11:20 am: Practicalities of ASM Usage Drug Therapy Considerations in Systemic Illnesses—Roohi Katyal, MD | ||||
11:50 am: Comorbidities and Adverse Outcomes in Epilepsy—Nuria Lacuey, MD, PhD | ||||
12:20 pm: Q&A | ||||
12:30 pm: Lunch | ||||
PM Session | ||||
Workup/Management of Drug Resistant Epilepsy and Board Review | ||||
Surgical Therapy | ||||
1:15 pm: Presurgical Workup—Jay Gavvala, MD | ||||
1:45 pm: Intracranial EEG/SEEG Including Cortical Mapping—Samden Lhatoo, MD | ||||
2:15 pm: Neuromodulation—Sandipan Pati, MD | ||||
2:45 pm: SEEG and Minimally Invasive Approaches (Surgical Therapy)—Nitin Tandon, MD | ||||
3:15 pm: Q&A | ||||
3:25 pm: Break | ||||
3:40 pm: Board Review Questions—Katherine Harris, MD, and Shilpa Reddy, MD | ||||
5:40 pm: Adjourn |
For more information, email tirn.events@uth.tmc.edu.